Evaluation of the Mitigatory Potential of Nigella sativa Oil on Cisplatin-Induced Toxicity in the Prefrontal Cortex of Adult Wistar Rats

References

[1] World Health Organization/International Agency for Research on Cancer (WHO/IARC), World Cancer Report: Cancer Research for Cancer Prevention. Lyon: IARC Press, 2020.

[2] S. Dasari and P. B. Tchounwou, "Cisplatin in cancer therapy: Molecular mechanisms of action," Eur. J. Pharmacol., vol. 740, pp. 364–378, 2014.

[3] G. Ciarimboli, "Anticancer platinum drugs update," Biomolecules, vol. 11, no. 11, p. 1637, 2021.

[4] N. A. G. dos Santos, R. S. Ferreira, and A. C. dos Santos, "Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents," Food Chem. Toxicol., vol. 136, p. 111079, 2020.

[5] A. H. Alhowail, "Cisplatin induces hippocampal neurotoxicity and cognitive impairment in rats through neuroinflammation, oxidative stress, and overexpression of glutamatergic receptors mRNA," Front. Pharmacol., vol. 16, p. 1592511, 2025.

[6] A. Areti, V. G. Yerra, V. Naidu, and A. Kumar, "Oxidative stress and nerve damage: Role in chemotherapy-induced peripheral neuropathy," Redox Biol., vol. 2, pp. 289–295, 2014.

[7] D. T. Jones and J. Graff-Radford, "Executive dysfunction and the prefrontal cortex," Continuum (Minneap. Minn.), vol. 27, no. 6, pp. 1586–1601, 2021.

[8] E. O. Olufunmilayo, M. B. Gerke-Duncan, and R. M. D. Holsinger, "Oxidative stress and antioxidants in neurodegenerative disorders," Antioxidants, vol. 12, no. 2, p. 517, 2023.

[9] R. Vukovic, D. Selakovic, J. S. Katanic Stankovic, I. Kumburovic, N. Jovicic, and G. Rosic, "Alteration of oxidative stress and apoptotic markers in the rat prefrontal cortex influence behavioral response induced by cisplatin and N-acetylcysteine in the tail suspension test," J. Integr. Neurosci., vol. 20, no. 3, pp. 711–718, 2021.

[10] O. M. Ighodaro and O. A. Akinloye, "First line defence antioxidants—superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid," Alexandria J. Med., vol. 54, no. 4, pp. 287–293, 2018.

[11] M. J. Esteban-Amo, P. Jiménez-Cuadrado, P. Serrano-Lorenzo, M. Á. de la Fuente, and M. Simarro, "Succinate dehydrogenase and human disease: Novel insights into a well-known enzyme," Biomedicines, vol. 12, no. 9, p. 2050, 2024.

[12] P. Kumar, A. Nagarajan, and P. D. Uchil, "Analysis of cell viability by the lactate dehydrogenase assay," Cold Spring Harb. Protoc., vol. 2018, no. 6, p. pdb.prot095497, 2018.

[13] J. D. Bancroft, S. K. Suvarna, and C. Layton, Bancroft's Theory and Practice of Histological Techniques, 8th ed. Philadelphia, PA: Elsevier, 2019.

[14] A. Ahmad et al., "A review on therapeutic potential of Nigella sativa: A miracle herb," Asian Pac. J. Trop. Biomed., vol. 3, no. 5, pp. 337–352, 2013.

[15] N. Isaev, E. Genrikhs, and E. Stelmashook, "Antioxidant thymoquinone and its potential in the treatment of neurological diseases," Antioxidants, vol. 12, p. 433, 2023.

[16] A. A. Al-Majed, A. R. Abd-Allah, O. A. Al-Shabanah, and A. M. Mostafa, "Molecular mechanisms and signalling pathways of black cumin (Nigella sativa) and its active constituent, thymoquinone: A review," Phytomedicine, vol. 113, p. 154759, 2023.

[17] Y. M. Janloo et al., "Effect of hydro-alcoholic extract of Nigella sativa on cisplatin-induced memory impairment and brain oxidative stress status in male rats," Avicenna J. Phytomed., vol. 14, no. 1, pp. 13–22, 2024.

[18] H. A. Elkattawy, R. H. M. Soliman, N. M. Mohamed, et al., "Nigella sativa oil (NSO): A game-changing neurorestorative strategy in cisplatin neurocognitive toxicity," Tissue Cell, vol. 98, p. 103190, 2026.

[19] S. A. Adelakun, B. Ogunlade, J. A. Aniah, and O. N. Akinyemi, "Neuroprotective mechanisms and ameliorative activities of quercetin in cisplatin-induced cerebellum neurotoxicity in rat models," Brain Disord., vol. 16, p. 100166, 2024.

[20] I. Edagha, A. N. Aquaisua, B. C. Akpan, et al., "Quercetin 100 mg/kg fails to mitigate cisplatin-induced neurotoxicity in adult Wistar rats," J. Exp. Clin. Anat., vol. 21, no. 2, pp. 1–10, 2024.

[21] National Institutes of Health, Guide for the Care and Use of Laboratory Animals, 8th ed. Washington, DC: National Academies Press, 2011.

[22] H. Ohkawa, N. Ohishi, and K. Yagi, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction," Anal. Biochem., vol. 95, no. 2, pp. 351–358, 1979.

[23] P. G. Cabaud and F. Wroblewski, "Colorimetric measurement of lactic dehydrogenase activity of body fluids," Am. J. Clin. Pathol., vol. 30, no. 3, pp. 234–236, 1958.

[24] B. Michael et al., "Evaluation of organ weights for rodent and non-rodent toxicity studies: A review of regulatory guidelines and a survey of current practices," Toxicol. Pathol., vol. 35, no. 5, pp. 742–750, 2007.

[25] H. Kim et al., "The effect of ginger extract on cisplatin-induced acute anorexia in rats," Front. Pharmacol., vol. 14, p. 1267254, 2023.

[26] C. A. Oliveira et al., "An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: Characteristics, common molecular mechanisms, and current clinical management," Clin. Exp. Nephrol., vol. 28, no. 8, pp. 711–727, 2024.

[27] D. Min, B. Kim, S.-G. Ko, and W. Kim, "Effect and mechanism of herbal medicines on cisplatin-induced anorexia," Pharmaceuticals, vol. 15, no. 2, p. 208, 2022.

[28] B. Salehi et al., "Nigella plants—traditional uses, bioactive phytoconstituents, preclinical and clinical studies," Front. Pharmacol., vol. 12, p. 625386, 2021.

[29] X. Huo, T. M. Reyes, C. J. Heijnen, and A. Kavelaars, "Cisplatin treatment induces attention deficits and impairs synaptic integrity in the prefrontal cortex in mice," Sci. Rep., vol. 8, p. 17400, 2018.

[30] M. Altunkaya, M. B. Ateş, A. Bulut, et al., "Cisplatin-induced toxicity in the hippocampus: A dose-dependent mechanism of damage," BMC Pharmacol. Toxicol., vol. 26, p. 215, 2025.

[31] B. Michael et al., "Evaluation of organ weights for rodent and non-rodent toxicity studies," Toxicol. Pathol., vol. 35, no. 5, pp. 742–750, 2007.

[32] M. R. Aslani, S. Saadat, and M. H. Boskabady, "Comprehensive and updated review on anti-oxidant effects of Nigella sativa and its constituent, thymoquinone, in various disorders," Iran. J. Basic Med. Sci., vol. 27, no. 8, pp. 923–951, 2024.

[33] N. M. Mahmud, L. Paraoan, N. Khaliddin, and T. A. Kamalden, "Thymoquinone in ocular neurodegeneration: Modulation of pathological mechanisms via multiple pathways," Front. Cell. Neurosci., vol. 16, p. 786926, 2022.

[34] J. S. Katanić Stanković, D. Selaković, and G. Rosić, "Oxidative damage as a fundament of systemic toxicities induced by cisplatin—the crucial limitation or potential therapeutic target?," Int. J. Mol. Sci., vol. 24, no. 19, p. 14574, 2023.

[35] G. Kursunluoglu, D. Taskiran, and H. A. Kayali, "The investigation of the antitumor agent toxicity and capsaicin effect on the electron transport chain enzymes, catalase activities and lipid peroxidation levels in lung, heart and brain tissues of rats," Molecules, vol. 23, no. 12, p. 3267, 2018.

[36] N. A. G. dos Santos, J. M. dos Santos, and A. C. dos Santos, "The role of oxidative stress and antioxidant therapy in cisplatin neurotoxicity: Preclinical evidence in the last decade," Arch. Toxicol., vol. 100, no. 6, pp. 2285–2305, 2026.

[37] N. G. Rummel, L. Chaiswing, S. Bondada, D. K. St. Clair, and D. A. Butterfield, "Chemotherapy-induced cognitive impairment: Focus on the intersection of oxidative stress and TNFα," Cell. Mol. Life Sci., vol. 78, pp. 6533–6540, 2021.

[38] A. Mihaylova et al., "Investigation of the immunomodulatory and neuroprotective properties of Nigella sativa oil in experimental systemic and neuroinflammation," Int. J. Mol. Sci., vol. 26, no. 5, p. 2235, 2025.

[39] S. Uzzan et al., "Chronic treatment with Nigella sativa oil exerts antimanic properties and reduces brain inflammation in rats," Int. J. Mol. Sci., vol. 25, no. 3, p. 1823, 2024.

@article{1722567,
      author = {Fakunle Ponle Bamidele, Babalola Abolore Tirimisiyu, Adewunmi Sulaimon Seun, Adejinmi Suliat Opeyemi},
      title = {Evaluation of the Mitigatory Potential of Nigella sativa Oil on Cisplatin-Induced Toxicity in the Prefrontal Cortex of Adult Wistar Rats},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {10},
      number = {2},
      pages = {2901-2912},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1722567.pdf},
      abstract = {Cisplatin remains a mainstay of modern cancer chemotherapy, but its clinical utility is constrained by dose-limiting toxicities, including neurotoxicity affecting the prefrontal cortex (PFC), a brain region central to executive function, working memory, and emotional regulation. This toxicity is driven by oxidative stress, neuroinflammation, and mitochondrial dysfunction, for which effective, well-tolerated adjunctive agents remain scarce. This study evaluated the mitigatory potential of Nigella sativa oil (NSO) against cisplatin-induced toxicity in the PFC of adult Wistar rats. Thirty adult male Wistar rats were randomly allocated into five groups of six: control, cisplatin-only (10 mg/kg, single intraperitoneal dose), NSO pretreatment plus cisplatin, cisplatin plus NSO post-treatment, and NSO-only (2 ml/kg orally, daily for 28 days). Body and brain weights were recorded, and prefrontal cortical tissue was analysed for oxidative stress markers (superoxide dismutase, catalase, lipid peroxidation), the pro-inflammatory cytokine tumour necrosis factor-alpha (TNF-α), and the mitochondrial enzymes lactate dehydrogenase and succinate dehydrogenase, alongside Haematoxylin and Eosin and Cresyl violet staining. Cisplatin produced a progressive decline in body weight, elevated lipid peroxidation, TNF-α and lactate dehydrogenase, reduced succinate dehydrogenase activity, and marked pyknosis, vacuolation and loss of Nissl substance in prefrontal cortical neurons. NSO administration, whether before or after cisplatin exposure, significantly attenuated these derangements, most consistently for the inflammatory, mitochondrial and histomorphological parameters, with a more modest effect on lipid peroxidation and no significant change in superoxide dismutase or catalase activity. These findings indicate that Nigella sativa oil possesses genuine, timing-independent neuroprotective potential against cisplatin-induced prefrontal cortical toxicity, supporting further molecular, behavioural and clinical evaluation of its candidacy as an adjunctive agent in platinum-based chemotherapy regimens.},
      keywords = {Prefrontal Cortex; Cisplatin; Nigella sativa Oil; Neurotoxicity; Neuroprotection; Wistar Rats},
      month = {August},
      doi = {https://doi.org/10.64388/IREV10I2-1722567}
  }